-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2019 to Q2 2024.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$20.9M, a 14.9% increase year-over-year.
- Taysha Gene Therapies, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$114M, a 7.66% increase year-over-year.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$112M, a 32.8% increase from 2022.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$166M, a 4.88% increase from 2021.
- Taysha Gene Therapies, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$175M, a 191% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)